A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma

Míreanna Comhchosúla

• Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
  le: Miyashiro, Michael J, et al.
  Foilsithe: (2010)
• Comparing the Efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the Treatment of Primary Open Angle Glaucoma
  le: Mishra, Deepak, et al.
  Foilsithe: (2014)
• A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
  le: Godfrey, David A, et al.
  Foilsithe: (2009)
• Effects of corneal thickness on the intraocular penetration of travoprost 0.004%
  le: Martinez-de-la-Casa, J M, et al.
  Foilsithe: (2012)
• A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
  le: Rhee, Douglas J, et al.
  Foilsithe: (2008)